Worldwide Market Opportunities for Hemoglobinopathies Treatment, 2019-2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 23, 2019--The “Global Hemoglobinopathies Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The hemoglobinopathies treatment market will register a CAGR of almost 11% by 2023.
Development of gene therapy to drive growth in the market
The advances of regenerative medicines in the clinical phases are expected to fuel growth of the global hemoglobinopathies treatment market.
Strong pipeline and expected approvals of late-stage molecule
The market is witnessing an acute lack of approved therapies, these late-stage pipeline molecules are expected to gain momentum during the forecast period, which will fuel the market growth.
Product recalls and tedious drug approval process
The strict regulations for providing the marketing approval for therapeutics that are being developed for the treatment of hemoglobinopathies is likely to pose a threat to the market.
Key PlayersApoPharma Bristol-Myers Squibb Emmaus Medical Medunik USA Novartis
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 04: MARKET SIZINGMarket definition Market sizing 2018 Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY TYPEComparison by type Sickle cell disease - Market size and forecast 2018-2023 Thalassemia - Market size and forecast 2018-2023 Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPEGeographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity
PART 09: DRIVERS AND CHALLENGES
PART 10: VENDOR LANDSCAPE
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPEOverview Landscape disruption Competitive scenario
PART 13: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors ApoPharma Bristol-Myers Squibb Emmaus Medical Medunik USA Novartis
For more information about this report visit https://www.researchandmarkets.com/research/r76lgr/worldwide_market?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190123005549/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Hematological Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/23/2019 10:43 AM/DISC: 01/23/2019 10:43 AM